Few Patients With Positive Margins After Basal Cell Excision Have Recurrence
Recurrence developed in more patients who did not receive additional treatment and in fewer receiving nonsurgical treatments
Abrocitinib Effective, Tolerated for Prurigo Nodularis, Chronic Pruritus
Decrease in Peak Pruritus Numeric Rating Scale for PN, chronic pruritus of unknown origin patients
Nonsignificant Survival Benefit Seen for Dabrafenib, Trametinib in Melanoma
Consistent survival benefit seen across several prespecified subgroups, including those with a BRAF V600E mutation
2021 to 2022 Saw Decrease in Telemedicine Use in Past 12 Months
Decrease seen across sociodemographic and geographic characteristics, including sex, family income, education, region, urbanization level
Approximately 7 Percent of U.S. Population Uninsured in 2023
10.9 percent of adults aged 18 to 64 years were uninsured at the time of interview in 2023, as were 3.9 percent of children aged 0 to 17 years
Lebrikizumab Tied to Sustained Atopic Dermatitis Treatment Effect
Findings seen despite negligible remaining lebrikizumab serum concentrations following treatment withdrawal
Pandemic-Era Tax Credits Made Healthcare More Affordable, But They’re Set to Expire
No Evidence That Live Vaccines Are Unsafe for Patients on Dupilumab
Systematic review shows vaccine efficacy not affected by dupilumab in general
Health Care Spending Growth Projected to Outpace GDP to 2032
National health expenditures projected to have increased 7.5 percent in 2023, when COVID-19 public health emergency ended
Adverse Effects of Medical Treatment Increasing Worldwide
In high sociodemographic index region, age effects showed higher incidence rate in older adults
